Asia Pharma Expo 2024

An international exhibition on COMPLETE pharma manufacturing focusing on the South Asian pharmaceutical industries. Launched in 2003, are successfully completing 22 years in Bangladesh and have always remained the growth partners for the Bangladesh pharmaceutical industry.

 ASIA LAB EXPO:

The concurrent exhibition features the complete spectrum of Analytical & Biotech Lab instruments, Reagents & Lab-Chemicals, Glassware, Lab-Ware and Lab-Consumables.

• CONTRACT MANUFACTURING PAVILION: A Special Pavilion for Contact Manufacturers at ASIA PHARMA EXPO 2024 to display the complete product range and manufacturing facilities to the Overseas Buyers

 

• One of the fastest growing pharma economies of the world

• The rapid growth rate to meet the Demand & Supply statistics of Bangladesh has attracted the global attention

• Over-all growth rate of the Bangladesh pharma industry: 18%

• No. of pharma manufacturing facilities are more than 340

• With the highest exports of the formulation, Bangladesh offers all the advantages for its strategic location in the South Asian pharma region

• Based on WTO meet / Doha declaration, Bangladesh will able to produce drugs which are still under Patent protection until year 2033

670+ Expected Exhibiting Companies

32 Expected Countries

1,25,000 Sq. Ft. Floorspace

12,700+ Expected Pharma Trade Attendees

 

The pharmaceutical sector of Bangladesh is progressing multifold. Apart from meeting the domestic demands of pharma formulations, the pharma industry is also earning huge foreign exchange from the exports. With the existing market value of about USD 3 billion, the Bangladesh pharma manufacturing industry is rapidly marching ahead with great potential as 98% of the country’s total demand for medicine is being met by nearly 300 domestic manufacturers, which is a milestone in the history of the Bangladesh pharmaceutical industry. At the same time, these local manufacturers are exporting as well to more than 142 countries across the world.

The anticipated market size of the Bangladesh pharmaceutical industry is more than USD 6 billion by 2025 with an absolute growth of 114% from 2019 levels, while the pharma exports of Bangladesh is likely to cross USD 450 Million by 2025. The share of the local manufacturing companies is above 90%.

An encouraging development is more than 47 units at API Manufacturing Park are coming up near Dhaka. The Bangladesh pharma industry now meets around 98% of the local demand for medicines, which is a milestone in the history of the pharmaceutical industry.